Vascular K+ channel openers such as cromakalim, nicorandil, and pinacidil potently stimulate 86Rb+
K+ channel openers are a new class of molecules that have attracted general interest because of their potent antihypertensive activity in vivo and vasorelaxant activity in vitro (1) . This class of compounds includes molecules of different structures, the best known of which are cromakalim, nicorandil, pinacidil, and minoxidil sulfate. They open K+ channels and thereby hyperpolarize smooth muscle cells and decrease contraction. Both cromakalim and pinacidil (as well as its derivative P1075) have also been shown to be active in the heart cell; they shorten the action-potential duration and produce a negative inotropic effect (2) (3) (4) (5) . The effect of cromakalim in smooth muscle cells as well as in heart cells is inhibited by glibenclamide (2, 6, 7) , an antidiabetic sulfonylurea that has been shown to be a specific blocker of ATPregulated K+ (KATP) channels (8) . It is for this reason that it has been suggested that K+ channel openers actually act on KATP channels (2, 6, 7, 9) .
The purpose of this paper is to gain more information concerning the mechanism of action of these K+ channel openers in the nervous system, which is known to contain both KATP channels (10) and sulfonylurea receptors (11) (12) (13) . The brain area that has been selected for this work is the substantia nigra (SN), a region that has been found to have the highest density of receptors for sulfonylureas (14) . Cromakalim, nicorandil, and pinacidil do open K+ channels in this important area ofthe central nervous system, and these channels have an important role in the release of the inhibitory transmitter y-aminobutyric acid (GABA) from SN terminals. (15) . Individual experiments were performed with several wells (2-3), and experiments were repeated n times. The results were calculated as the mean of all experiments ± SEM. K0. values (half-maximal effects) were determined by least-squares fit of the data to a sigmoidal function as described (16) .
MATERIALS AND METHODS
For dose-response curves, basal rates of 86Rb+ and of [3H]GABA efflux were subtracted at the level of the top peak from activated rates as described (15) .
RESULTS
The activity of cromakalim-sensitive K+ channels in smooth muscle cells has previously been successfully studied with 'Rb+-efflux experiments (9, 17) . 86Rb+-efux techniques have also been used with success to characterize the phar- tTo whom reprint requests should be addressed.
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Pharmacology: Schmid-Antomarchi et al. macological properties and the mechanism of regulation of KATP channels in insulinoma cells (18 We have recently demonstrated that both glucose and sulfonylureas activate neurotransmitter release in SN through an inhibition of KATP channels (19) . Fig. 4 shows that an excellent linear relation in the structure-function relationship is observed between the affinities of the different K+ channel openers for inhibiting the gliquidone-activated [3H]GABA release and the affinities of the different openers for stimulating 86Rb+ efflux from SN slices. DISCUSSION The description of the mechanism of action of cromakalim (1, 20) It is only recently (21) (22) (23) that an action of these openers on the central nervous system has been recognized. Cromakalim has been shown to reduce excitability in CA3 hippocampal cells (21) and to display antiepileptic properties in a model of drug-induced epilepsia (22, 23) . Therefore, it appeared to us that it was important to try to establish the molecular basis of the action of these compounds in brain cells. The choice of SN to study the mechanism of action of cromakalim, pinacidil, nicorandil, and their analogs was linked to the fact that, both in smooth muscle and in cardiac muscle (2, 6, 20, 24) , the target of these drugs seems to be the sulfonylurea-sensitive KATP channel. It is in SN that one finds the highest amount of sulfonylurea receptors in the brain (14) . channels. They triggered 86Rb+ efflux from SN as they do in smooth muscle (1, 9, 20) , and this efflux was inhibited by sulfonylureas.
The most obvious conclusion from this work is that cromakalim, nicorandil, pinacidil, and parent compounds open sulfonylurea-sensitive K+ channels in SN. Minoxidil sulfate, which is active in smooth muscle at concentrations in the 0.1-1 ,uM range (25, 26) and used therapeutically (25) (Fig. 1) ; and (ifi) pinacidil and its analog P1075 are nearly equipotent on K+ channels in SN (Fig. 1 (Fig. 4) suggests that the inhibition of the neurotransmitter release, like the inhibition of contraction in smooth muscle cells (1, 20) , is linked to the K+ channel-opening capacity of these compounds. The most probable mechanism of action is: (i) opening of K+ channels, (ii) hyperpolarization of previously depolarized terminals (in SN pars reticulata) to a new membrane potential value far from the threshold of activation of Ca2l channels that provide Ca2l entry for GABA secretion, and (iii) inhibition of Ca2l entry and thereby of GABA secretion. A similar mechanism has been proposed to explain the inhibitory effect of hormones such as galanin and somatostatin in insulin secretion from pancreatic beta cells (27) (28) (29) .
All ionic channel openers have become important tools in neurobiological research. This is particularly the case for openers of voltage-sensitive Na+ channels, such as veratridine and batrachotoxin (30, 31) , or for openers of voltagesensitive L-type Ca2" channels, such as Bay K 8644 (32) (33) (34) (35) .
Moreover, while a lot of procedures are available to depolarize membranes [K+ depolarization, veratridine or batrachotoxin treatment, ouabain inhibition of (Na+,K+)-ATPase, etc.], creating a hyperpolarization is always more difficult. Therefore, compounds such as (-)-cromakalim or nicorandil will undoubtedly become tools of a very general use in neurobiology.
Another potential application of the results presented in this work concerns the identification of the receptors of K+ channel openers using radiolabeled ligands. Such an approach has not been successful until now in smooth muscle cells probably because of the relatively modest affinity of the drug for their binding component. The situation is different in SN in which affinities in the 10 nM range for (-)-cromakalim should permit a characterization of the receptor site. A receptor characterization might even be possible with labeled nicorandil. A biochemical identification of the binding site of at least one of these compounds would be essential to know whether all of the different compounds presented in Fig. 1 bind to the same receptor site, or else, if there are, as for Ca2+ channel effectors (32) , several types of receptor sites for the different families of compounds.
